150 related articles for article (PubMed ID: 37559582)
1. KORTUC, a novel hydrogen peroxide‑based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer.
Shimbo T; Yoshida K; Nakata M; Kobata K; Ogawa T; Kihara A; Sato C; Hori A; Takeno S; Yoshioka H; Akiyama H; Nihei K
Oncol Lett; 2023 Sep; 26(3):378. PubMed ID: 37559582
[TBL] [Abstract][Full Text] [Related]
2. High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report.
Nakata M; Yoshida K; Shimbo T; Yoshikawa N; Yoshioka H; Hori A; Sato C; Uesugi Y; Kogata Y; Masui K; Murakami N; Kashihara T; Akiyama H; Tselis N; Ohmichi M; Nihei K
J Contemp Brachytherapy; 2020 Dec; 12(6):606-611. PubMed ID: 33437310
[TBL] [Abstract][Full Text] [Related]
3. New enzyme-targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer.
Shimbo T; Nakata M; Yoshioka H; Sato C; Hori A; Kimura K; Iwamoto M; Yoshida K; Uesugi Y; Akiyama H; Nihei K
Mol Clin Oncol; 2021 Nov; 15(5):241. PubMed ID: 34650808
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancer.
Aoyama N; Ogawa Y; Yasuoka M; Takahashi M; Iwasa H; Miyatake K; Yamanishi T; Hamada N; Tamura T; Nishioka A; Yamagami T
Oncol Lett; 2016 Jul; 12(1):29-34. PubMed ID: 27347095
[TBL] [Abstract][Full Text] [Related]
5. Actual practice of Kochi oxydol radiation therapy for unresectable carcinomas by intra-tumoral administration of hydrogen peroxide as a radiosensitizer.
Obata S; Ishimaru Y; Miyagi S; Nakatake M; Kuroiwa A; Ohta Y; Kan T; Kanegae S; Inoue Y; Nishizato R; Miyazaki K
Mol Clin Oncol; 2022 Mar; 16(3):68. PubMed ID: 35154708
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II).
Ogawa Y; Kubota K; Ue H; Kataoka Y; Tadokoro M; Miyatake K; Tsuzuki K; Yamanishi T; Itoh S; Hitomi J; Hamada N; Kariya S; Fukumoto M; Nishioka A; Inomata T
Int J Oncol; 2009 Mar; 34(3):609-18. PubMed ID: 19212665
[TBL] [Abstract][Full Text] [Related]
7. New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms.
Ogawa Y; Ue H; Tsuzuki K; Tadokoro M; Miyatake K; Sasaki T; Yokota N; Hamada N; Kariya S; Hitomi J; Nishioka A; Nakajima K; Ikeda M; Sano S; Inomata T
Oncol Rep; 2008 Jun; 19(6):1389-94. PubMed ID: 18497941
[TBL] [Abstract][Full Text] [Related]
8. Non-surgical care for locally advanced breast cancer: radiologically assessed therapeutic outcome of a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II) with systemic chemotherapy.
Miyatake K; Kubota K; Ogawa Y; Hamada N; Murata Y; Nishioka A
Oncol Rep; 2010 Nov; 24(5):1161-8. PubMed ID: 20878106
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic response to a novel enzyme-targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane.
Aoyama N; Ogawa Y; Yasuoka M; Iwasa H; Miyatake K; Yoshimatsu R; Yamanishi T; Hamada N; Tamura T; Kobayashi K; Murata Y; Yamagami T; Miyamura M
Oncol Lett; 2017 Jan; 13(1):69-76. PubMed ID: 28123524
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic results of a novel enzyme-targeting radiosensitization treatment, Kochi oxydol-radiation therapy for unresectable carcinomas II, in patients with stage I primary breast cancer.
Aoyama N; Ogawa Y; Yasuoka M; Ohgi K; Iwasa H; Miyatake K; Yoshimatsu R; Yamanishi T; Hamada N; Tamura T; Kobayashi K; Murata Y; Miyamura M; Yamagami T
Oncol Lett; 2017 Jun; 13(6):4741-4747. PubMed ID: 28599475
[TBL] [Abstract][Full Text] [Related]
11. Development of a Novel Enzyme-Targeting Radiosensitizer (New KORTUC) Using a Gelatin-Based Hydrogel Instead of a Sodium Hyaluronate.
Morita-Tokuhiro S; Ogawa Y; Yokota N; Tsuzuki A; Oda H; Ishida N; Aoyama N; Nishioka A
Cancers (Basel); 2016 Jan; 8(1):. PubMed ID: 26751477
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel enzyme-targeting radiosensitizer (KORTUC) containing hydrogen peroxide for intratumoral injection for patients with low linear energy transfer-radioresistant neoplasms.
Tokuhiro S; Ogawa Y; Tsuzuki K; Akima R; Ue H; Kariya S; Nishioka A
Oncol Lett; 2010 Nov; 1(6):1025-1028. PubMed ID: 22870106
[TBL] [Abstract][Full Text] [Related]
13. Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging.
Yaogawa S; Ogawa Y; Morita-Tokuhiro S; Tsuzuki A; Akima R; Itoh K; Morio K; Yasunami H; Onogawa M; Kariya S; Nogami M; Nishioka A; Miyamura M
Cancers (Basel); 2015 Dec; 8(1):. PubMed ID: 26703733
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of image-guided enzyme-targeting radiosensitization and intraoperative radiotherapy for locally advanced unresectable pancreatic cancer.
Nishioka A; Ogawa Y; Miyatake K; Tadokoro M; Nogami M; Hamada N; Kubota K; Kariya S; Kohsaki T; Saibara T; Okabayashi T; Hanazaki K
Oncol Lett; 2014 Jul; 8(1):404-408. PubMed ID: 24959285
[TBL] [Abstract][Full Text] [Related]
15. Computed Tomography Demonstration of the Production and Distribution of Oxygen Gas Following Intratumoral Injection of a New Radiosensitizer (KORTUC) for Patients with Breast Cancer-Is Intratumoral Injection Not an Ideal Approach to Solve the Major Problem of Tumor Hypoxia in Radiotherapy?
Hayashi N; Ogawa Y; Kubota K; Okino K; Akima R; Morita-Tokuhiro S; Tsuzuki A; Yaogawa S; Nishioka A; Miyamura M
Cancers (Basel); 2016 Apr; 8(4):. PubMed ID: 27043633
[TBL] [Abstract][Full Text] [Related]
16. Safety and effectiveness of a new enzyme-targeting radiosensitization treatment (KORTUC II) for intratumoral injection for low-LET radioresistant tumors.
Ogawa Y; Kubota K; Ue H; Tadokoro M; Matsui R; Yamanishi T; Hamada N; Kariya S; Nishioka A; Nakajima H; Tarutani M; Sano S
Int J Oncol; 2011 Sep; 39(3):553-60. PubMed ID: 21667020
[TBL] [Abstract][Full Text] [Related]
17. Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer.
Ogawa Y; Kubota K; Aoyama N; Yamanishi T; Kariya S; Hamada N; Nogami M; Nishioka A; Onogawa M; Miyamura M
Cancers (Basel); 2015 Nov; 7(4):2277-89. PubMed ID: 26593948
[TBL] [Abstract][Full Text] [Related]
18. Re-irradiation with interstitial brachytherapy in uterine cancer patients with vaginal recurrence after post-operative pelvic irradiation.
Murofushi KN; Tanaka R; Ohkawa A; Numajiri H; Minakami S; Okumura T; Sakurai H
J Contemp Brachytherapy; 2022 Feb; 14(1):60-65. PubMed ID: 35233236
[TBL] [Abstract][Full Text] [Related]
19. High-Dose-Rate Interstitial Brachytherapy for Deeply Situated Gynecologic Tumors Guided by Combination of Transrectal and Transabdominal Ultrasonography: A Technical Note.
Shimizu Y; Murakami N; Chiba T; Kaneda T; Okamoto H; Nakamura S; Takahashi A; Kashihara T; Takahashi K; Inaba K; Okuma K; Nakayama Y; Itami J; Igaki H
Front Oncol; 2021; 11():808721. PubMed ID: 35155202
[TBL] [Abstract][Full Text] [Related]
20. Salvage Re-irradiation With Single-modality Interstitial Brachytherapy for the Treatment of Recurrent Gynaecological Tumours in the Pelvis: A Multi-institutional Study.
Raziee H; D'Souza D; Velker V; Barnes E; Taggar A; Mendez L; Leung E
Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):43-51. PubMed ID: 31402286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
